Home

Bafna Pharmaceuticals Ltd 52 Week Low

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

YEARLOW

₹ 69

Last updated on: Feb 21, 2025

Key Highlights

  • The 52 Week Low of Bafna Pharmaceuticals Ltd is ₹ 69 as of 21 Feb 25 .

Company Fundamentals for Bafna Pharmaceuticals Ltd

Market Price of Bafna Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Bafna Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Feb 202571.95
18 Feb 202568.54
17 Feb 202571.36
14 Feb 202575
13 Feb 202578.79
12 Feb 202578.79
11 Feb 202575.1
10 Feb 202578.35
05 Feb 202579.36
04 Feb 202579.36

Asset Value vs Market Value of Bafna Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Bafna Pharmaceuticals Ltd News Hub

Bafna Pharmaceuticals reports standalone net loss of Rs 0.72 crore in the June 2024 quarter

Net loss of Bafna Pharmaceuticals reported to Rs 0.72 crore in the quarter ended June 2024 as agains

Read more

13 Aug 24

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024

Read more

10 Aug 24

Bafna Pharmaceuticals to convene AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on

Read more

04 Sept 24

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on

Read more

05 Sept 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Bafna Pharmaceuticals Ltd

Why is it important to track the 52-week low of Bafna Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Bafna Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Bafna Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Bafna Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Bafna Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Bafna Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Bafna Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Bafna Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Bafna Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Bafna Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Bafna Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Bafna Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Bafna Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions